Drug maker UCB is seeking approval for one of its drugs as a standalone therapy for epilepsy.
Actavis is looking to become the first to market a generic drug for epilepsy, the company said.
Drug maker Impax Labs is hoping to become the first to market a generic version of a drug used to treat incontinence and overactive bladder, the company said Wednesday.
UCB has launched a new drug for treating Parkinson's disease and restless legs syndrome, the company said Monday.
The Food and Drug Administration has approved a patch for treating restless legs syndrome and Parkinson's disease.
The Food and Drug Administration has approved a drug for epilepsy made by Hi-Tech Pharmacal, the drug maker said Wednesday.
A wave of patent expirations over the next several years will open up a broad swath of drugs to generic competition, and India's Lupin Pharmaceuticals is looking to benefit, according to published reports.
Drug maker UCB and Harvard University have entered a research alliance that is designed to advance ongoing Harvard research projects along the drug development pathway.
UCB announced that it will add two members to its executive committee, effective July 1.
An oral liquid version of an epilepsy drug made by UCB has become available, UCB...